---
document_datetime: 2023-09-21 19:32:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_en.pdf
document_name: yttriga-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7082064
conversion_datetime: 2025-12-28 12:43:20.118531
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | (Invented) name   | Strength    | Pharmaceutical Form                     | Route of Administration   | Packaging    | Package size             |
|-----------------|-------------------|-------------|-----------------------------------------|---------------------------|--------------|--------------------------|
| EU/1/05/322/001 | Yttriga           | 0.1-300 GBq | Radiopharmaceutical precursor, solution | Extracorporeal use        | vial (glass) | 1 vial (V-shaped bottom) |
| EU/1/05/322/002 | Yttriga           | 0.1-300 GBq | Radiopharmaceutical precursor, solution | Extracorporeal use        | vial (glass) | 1 vial (flat bottom)     |